ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID) · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
hivpreventionhumanimmunodeficiencyvirusimmuneresponse
human immunodeficiency virus prevention, human immunodeficiency virus (hiv), human immunodeficiency virus, immune response, neutralizing antibodies, hiv prevention, cellular immunogenicity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871319
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.